Back to Search
Start Over
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.
- Source :
-
Cell reports [Cell Rep] 2018 Jun 26; Vol. 23 (13), pp. 3946-3959.e6. - Publication Year :
- 2018
-
Abstract
- Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPĪ± checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPĪ± interactions.<br /> (Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Antibodies, Monoclonal therapeutic use
CD11b Antigen metabolism
CD18 Antigens metabolism
CD47 Antigen metabolism
Cell Line, Tumor
Female
Humans
Male
Melanoma, Experimental metabolism
Melanoma, Experimental pathology
Mice
Mice, Inbred C57BL
Neoplasms drug therapy
Neoplasms immunology
Neoplasms pathology
Receptors, IgG metabolism
Receptors, Immunologic genetics
Receptors, Immunologic metabolism
Transplantation, Homologous
Antibody-Dependent Cell Cytotoxicity
Neutrophils immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2211-1247
- Volume :
- 23
- Issue :
- 13
- Database :
- MEDLINE
- Journal :
- Cell reports
- Publication Type :
- Academic Journal
- Accession number :
- 29949776
- Full Text :
- https://doi.org/10.1016/j.celrep.2018.05.082